Search

everythinglearnresearchcommunity

for

Search:↓

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A machine learning model called CATNIP can predict new uses for existing drugs, like using antidepressants for Parkinson's disease and a thyroid cancer drug for diabetes.

An 80-year-old patient grew new hair on a wound, showing that elderly people can still regenerate hair.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Aging can lead to poorer scalp and hair health, including less hair and more scalp diseases, which should be managed to help older people feel better.

A new compound was made that might help treat diseases related to male hormones.

Vitamin D is important for skin health and can help improve various skin conditions.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Over 30 potential cancer prevention treatments are being tested, with some showing promise in early research.

Dietary phytoestrogens do not significantly affect testicular cancer risk.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

The conclusion is that Pigmented Epithelioid Melanocytoma can start from hair follicle stem cells or from a mole on the skin.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

Oral dutasteride, minoxidil, and finasteride may help reduce hair loss in breast cancer survivors, but more research is needed.

Cancer patients, especially with blood cancers, face severe COVID-19 risks due to weakened immunity.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Taking 1 mg/day finasteride for hair loss significantly lowers PSA levels in men, which may affect prostate cancer screening.

The new method improves skin cancer detection in imbalanced datasets.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Chinese herbal medicine might help reduce chemotherapy side effects in breast cancer patients, but more high-quality research is needed.

NGAL may help maintain skin balance and is linked to skin disorders and cancers.

Mesenchymal Stem Cells (MSCs) are promising for multiple therapies, but more research is needed to fully understand and optimize their use.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Skin health and diseases are closely linked to metabolic processes.